Production (Stage)
Caribou Biosciences, Inc.
CRBU
$1.12
$0.010.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.29% | 2.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.29% | 2.62% | |||
| Cost of Revenue | -94.16% | 0.14% | |||
| Gross Profit | 102.20% | 0.04% | |||
| SG&A Expenses | -7.18% | 76.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.18% | 12.83% | |||
| Operating Income | -12.12% | -13.45% | |||
| Income Before Tax | -12.65% | -2.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.68% | -2.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.68% | -2.32% | |||
| EBIT | -12.12% | -13.45% | |||
| EBITDA | -12.56% | -13.91% | |||
| EPS Basic | -10.84% | -1.54% | |||
| Normalized Basic EPS | -12.33% | -15.16% | |||
| EPS Diluted | -10.84% | -1.54% | |||
| Normalized Diluted EPS | -12.33% | -15.16% | |||
| Average Basic Shares Outstanding | 1.67% | 0.78% | |||
| Average Diluted Shares Outstanding | 1.67% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||